Figure 11.
Cell viability and apoptosis in miRNA-transfected HFF cells after 24 h of butyrate treatment. ApoLive-Glo™ multiplex assay: fluorescence and luminescent signals for viability changes (A) miR-139, (B) miR-542 and normalized caspase activity for apoptosis changes, respectively (C) miR-139, (D) miR-542 in HFF cells transfected with butyrate-sensitizing miRNAs for 48 h, followed by 24 h of treatment with 0 mM or 2.5 mM butyrate, over a 72 h post-transfection period. Significant results are indicated by * p < 0.05, ** p < 0.01. NC = negative control mimic.
